Navigation Links
Genstar Names Michael Hurt to Its Strategic Advisory Board
Date:9/5/2007

CEO of Former Portfolio Company is a Proven Leader at Driving Growth

SAN FRANCISCO, Sept. 5 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of life sciences and healthcare services, industrial technology, business services and software, today announced the appointment of Michael L. Hurt to the firm's Strategic Advisory Board (SAB). The addition of Mr. Hurt, CEO of Altra Industrial Motion (Nasdaq: AIMC), a former Genstar portfolio company, increases to 18 the number of influential senior executives who are current or former leaders of major corporations and have joined the firm in this advisory capacity.

"I have known Mike for more than 15 years since my first LBO of the company he ran and he is a multi-talented executive who repeatedly has driven growth at the businesses he has overseen," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "The Genstar team has become familiar with Mike's ability to successfully lead organizations, most recently as head of our portfolio company Altra Holdings where he achieved spectacular growth and tripled operating profit in less than three years. We are very pleased that he will now provide the skills he has obtained over nearly 40 years of working with industrial technology businesses to our management teams as we grow our investments."

Mr. Hurt is currently CEO of Altra Industrial Motion, which designs, produces, and distributes a wide range of mechanical power transmission products that serve a variety of applications. Prior to leading Altra, he worked with Genstar as an advisor in the Industrial Technology area after retiring as the President and CEO of TB Wood's Corporation in November 2003. In addition to Altra, Mr. Hurt spent thirteen years at TB Wood's and 23 years with the Torrington Company, a division of Ingersoll Rand.

A graduate of Clemson University with a BSME degree in mechanical engineering, Mr. Hurt holds an MBA degree from Clemson-Furman University. He is a registered professional engineer.

The Genstar SAB includes executives from such leading companies as Pharmacia & Upjohn, Inc., CNA Insurance Companies, ITT Corporation, Deere & Co., Axia Health Management, MedImmune, Inc., Wild Oats Markets, WellPoint, Inc., NEN Life Science Products, and ICOS Corporation.

About Genstar Capital, LLC

Based in San Francisco, Genstar Capital (http://www.gencap.com) is a private equity investment firm that makes leveraged investments in quality middle- market companies. Genstar Capital works in partnership with management to transform its portfolio companies into industry-leading businesses. With more than $3 billion of committed capital under management and significant experience investing in businesses, Genstar focuses on selected segments of life science and healthcare services, industrial technology, business services and software services.


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Wisconsin IT association names Gee president, CEO
2. Quintessence Biosciences names new president
3. CDW names VP to handle Berbee merger
4. NimbleGen names CFO with capital-raising past
5. Cisco names Berbee a top partner of 2005
6. Cisco names Inacom most innovative partner
7. UW-Madison medical school names new dean
8. GE Healthcare names new CEO
9. Bruker AXS names new leadership
10. Sonic Foundry names new senior vice president
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 5, 2016 According to ... by Products (Consumable, Instruments, Automated Cell Expansion System), ... Stem Cell Research, Cancer, and Cell-Based Research), End-users ... - Global Revenue, Trends, Growth, Share, Size and ... the global cell expansion market is expected to ...
(Date:12/5/2016)... /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the "Company") ... Safety Monitoring Board (DSMB) for the Company,s Phase ... patients has completed a second planned safety review ... planned without any modifications. The DSMB reviewed available ... efficacy concerns were identified. The DSMB will conduct ...
(Date:12/5/2016)... , Dec. 5, 2016  Eisai Inc. ... open-label two-year study of rufinamide, which were presented ... Epilepsy Society (AES) held from December 2-6 in ... final two-year safety, tolerability and cognitive data showed ... experienced similar safety and tolerability profiles, cognitive development ...
(Date:12/5/2016)... 2016 The U.S. Biotechnology industry ... billion of revenue and some $890 billion of total ... global biopharmaceuticals, and this figure is expected to exceed ... up these four equities for assessment: Northwest Biotherapeutics Inc. ... ACAD ), Acorda Therapeutics Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:12/5/2016)... WASHINGTON , Dec. 5, 2016  The ... (NIJ), today published "Can CT Scans Enhance or ... examines the potential of supporting or replacing forensic ... a CT scan. In response to ... NIJ is exploring using CT scans as a ...
(Date:12/2/2016)... 1, 2016 The report "Biometric ... Future Technology (Iris Recognition System), Vehicle Type (Passenger ... Forecast to 2021", published by MarketsandMarkets, the market ... 2016, and is projected to grow to USD ... 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:12/2/2016)...   SoftServe , a global digital technology ... electrocardiogram (ECG) biosensor analysis system for continuous driver ... The smart system ensures device-to-device communication between ECG ... mobile devices to easily ,recognize, and monitor users ... technology advances, so too must the security systems ...
Breaking Biology News(10 mins):